Julie Vanderpoel

Impact of Co-morbidities and Patient Characteristics on International Normalized Ratio Control Over Time in Patients With Nonvalvular Atrial Fibrillation

Winnie W. Nelson, Jiyoon Choi, Julie Vanderpoel et al. · The American Journal of Cardiology · 2013 · 59 citations · Full text

Hypertension, Heart Failure, Preventive Cardiology +24

Total cost of testing for genomic alterations associated with next-generation sequencing versus polymerase chain reaction testing strategies among patients with metastatic non-small cell lung cancer

Julie Vanderpoel, Andrea L. Stevens, Bruno Émond et al. · Journal of Medical Economics · 2022 · 48 citations · Full text

Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users

François Laliberté, Michel Cloutier, Concetta Crivera et al. · Advances in Therapy · 2015 · 28 citations · Full text

Patient Satisfaction with Warfarin- and Non–Warfarin-Containing Thromboprophylaxis Regimens for Atrial Fibrillation

Craig I Coleman, Stacey M Coleman, Julie Vanderpoel et al. · Journal of Investigative Medicine · 2013 · 22 citations

Factors associated with ‘caregiver burden’ for atrial fibrillation patients

Craig I Coleman, Stacey M Coleman, Julie Vanderpoel et al. · International Journal of Clinical Practice · 2012 · 22 citations